Coverage
-
October 23, 2013
A former Bristol-Myers Squibb Co. executive on Wednesday was sentenced in New Jersey federal court to 366 days in prison for insider trading after admitting to purchasing stock options in a biotechnology company he knew BMS was preparing to acquire.
1 other articles on this case.
View all »